DAWN Smart Money
Day One Biopharmaceuticals, Inc.
1W: +0.3%
1M: +0.8%
3M: +80.2%
YTD: +143.3%
1Y: +189.4%
3Y: +69.9%
$21.53
Last traded 2026-04-24 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026209
Institutions Holding
-58 vs prior
0.0%
Ownership
-82.82%
0
New
0
Increased
205
Reduced
204
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | Blavatnik Len | 10% owner | U-U | 12,929,322 | $21.50 | $278.0M | Filing |
| 2026-04-23 | York Charles N II | officer: coo and cfo | D-Sale to Issuer | 312,025 | $— | $0 | Filing |
| 2026-04-23 | ACCESS INDUSTRIES MANAGEMENT, LLC | 10% owner | U-U | 12,929,322 | $21.50 | $278.0M | Filing |
| 2026-04-23 | Access Industries Holdings LLC | 10% owner | U-U | 12,929,322 | $21.50 | $278.0M | Filing |
| 2026-04-23 | AI Day1 LLC | 10% owner | U-U | 12,929,322 | $21.50 | $278.0M | Filing |
| 2026-04-23 | Josey John A. | director | D-Sale to Issuer | 72,292 | $— | $0 | Filing |
| 2026-04-23 | Holles Natalie C. | director | D-Sale to Issuer | 57,310 | $— | $0 | Filing |
| 2026-04-23 | Dubow Adam | officer: gen counsel & secretary | D-Sale to Issuer | 72,694 | $— | $0 | Filing |
| 2026-04-23 | Merendino Lauren | officer: chief commercial officer | D-Sale to Issuer | 60,157 | $— | $0 | Filing |
| 2026-04-23 | Bender Jeremy | officer: chief executive officer | D-Sale to Issuer | 204,643 | $— | $0 | Filing |
| 2026-04-23 | Bender Jeremy | officer: chief executive officer | D-Sale to Issuer | 20,204 | $— | $0 | Filing |
| 2026-04-23 | Bender Jeremy | officer: chief executive officer | D-Sale to Issuer | 147,702 | $— | $0 | Filing |
| 2026-04-23 | Bender Jeremy | officer: chief executive officer | D-Sale to Issuer | 18,197 | $— | $0 | Filing |
| 2026-04-23 | Bender Jeremy | officer: chief executive officer | D-Sale to Issuer | 300,000 | $— | $0 | Filing |
| 2026-04-23 | Bender Jeremy | officer: chief executive officer | D-Sale to Issuer | 808,285 | $— | $0 | Filing |
| 2026-04-23 | VASCONCELLES MICHAEL | officer: head of research and dev. | D-Sale to Issuer | 4,397 | $— | $0 | Filing |
| 2026-04-23 | Ramasastry Saira | director | D-Sale to Issuer | 40,485 | $— | $0 | Filing |
| 2026-02-17 | Dubow Adam | officer: gen counsel & secretary | S-Sale | 6,395 | $11.60 | $74K | Filing |
| 2026-02-17 | VASCONCELLES MICHAEL | officer: head of research and dev. | S-Sale | 2,728 | $11.60 | $32K | Filing |
| 2026-02-17 | York Charles N II | officer: coo and cfo | S-Sale | 6,065 | $11.60 | $70K | Filing |
| 2026-02-17 | Bender Jeremy | officer: chief executive officer | S-Sale | 15,459 | $11.60 | $179K | Filing |
| 2026-02-17 | Merendino Lauren | officer: chief commercial officer | S-Sale | 5,814 | $11.60 | $67K | Filing |
| 2025-11-25 | Bender Jeremy | officer: chief executive officer | G-Gift | 7,225 | $— | $0 | Filing |
| 2025-11-25 | Bender Jeremy | officer: chief executive officer | G-Gift | 300,000 | $— | $0 | Filing |
| 2025-11-17 | York Charles N II | officer: coo and cfo | S-Sale | 4,062 | $8.91 | $36K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||